Cell Surface Markers Identification: Market Research Report

January 2015 | 290 pages | ID: CE5B8BF94B3EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Cell Surface Markers Identification in US$ Million by the following Product Segments: Flow Cytometers, and Others. The Global market is further analyzed by the following Application Markets: Research, and Diagnosis. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -

• Abbott Laboratories
• BD Biosciences
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• CellaVision AB

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Flow Cytometers
Hematology Analyzers
Reagents

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

A Prelude
Increased Emphasis on Lab Automation Builds Opportunities
Market Outlook
Developed Regions: Major Revenue Contributors
Developing Regions: Hotspots for Future Growth
Healthcare Trends Influencing Demand for Healthcare Technologies in Developing Nations: A Review
Growing Healthcare Awareness
Increased Access to Healthcare
Proliferation of Medical Tourism
Economic Upheavals in the Recent Past & Impact on Healthcare & Research Equipment Market
Stable Spending Outlook Offers Opportunities for Market Growth

2. NOTEWORTHY MARKET TRENDS & GROWTH DRIVERS

Upward Trajectory in Med Tech Sector Gives Impetus to Market Growth
Cell Surface Markers Identification Assumes Critical Importance Amid Growing Prevalence of Chronic Diseases
Cell Surface Markers in Stem Cell Research
Select Cell Surface Marker s Used in Stem Cell Identification and Characterization
Increasing Significance in Cancer Research
Select Markers for Cancer Stem Cell Identification: A Snapshot

Table 1. Worldwide Incidence of Cancer (2010, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)

Table 2. New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 3. Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)

Clinical Management of Autoimmune Diseases
Flow Cytometry Remains the Gold Standard in HIV Testing and Monitoring

Table 4. Worldwide HIV Prevalence and New Infection Incidence (2014) in Millions (includes corresponding Graph/Chart)

Table 5. HIV Testing Service Penetration, by Region (2010-2014): Percentage Share Breakdown of Adult Population who received HIV Testing Services in Various Global Regions (includes corresponding Graph/Chart)

Increasing Investments on Advanced Equipment in Disease Diagnosis Underpin Volume Growth
High Uptake in Drug Discovery Applications Widens Market Prospects
Growing Focus on Data Management in Research Programs Extends Opportunities
Flow Cytometers: A Standard Research Tool
Technological Advances Boost Cytometric System Sales
Third-party Software – Easing Flow Cytometry Data Analysis and Sharing
Select Leading Software for Flow Cytometry
Hematology Analyzers Gain Traction in Cell Surface Marker Identification
Innovations in Hematology Analyzers Segment
Dry Reagents Find Increased Adoption

3. COMPETITION

Flow Cytometers Market Characterized by High Consolidation

Table 6. Leading Players in the Global Flow Cytometers Market (2014): Percentage Breakdown of Value Sales for Becton Dickinson and Company (BD)/BD Biosciences, Danaher/ Beckman Coulter and Others (includes corresponding Graph/Chart)

Specialist Players Dominate Hematology Analyzers Market
Software and Services: The New Area of Competition in Hematology Analyzers Segment

4. PRODUCT OVERVIEW

Introduction
Types of Cell Surface Markers
Applications of Cell Surface Marker Identification
In Assessing Aberrant Cell Populations
In Distinguishing Minimal Residual Disease
To Quantify Cell Populations
For Evaluating Cell Proliferation
In Identification of Foreign Cell Populations
In Ascertaining Haematological Condition
Product Segments
Flow Cytometers
Hematology Analyzers
Reagents
Kits
End Users
Healthcare Facilities
Research Entities

5. PRODUCT INTRODUCTIONS/LAUNCHES

EIDIA to Introduce HISCL KL-6 Marker Diagnostic Kit
Helomics to Unveil Precision Cellular Analytical Platform (PCAP)
Bio-Rad Laboratories Unveils VivaFix Cell Viability Assays
EMD Millipore Launches Amnis NFкB Translocation kit
Sysmex Unveils XN-L Series Automated Hematology Analyzer
Sysmex Launches LC-1000 Exfoliative Cell Analyser
Sysmex Rolls Out HISCL-800 Immunoassay System
HORIBA UK Unveils Pentra XLR Compact 5 Part DIFF Haematology Analyser
Roche Introduces AMH Fertility Marker
Diatron Group Unveils Abacus 3CT Hematology Analyzer
Beckman Coulter Launches UniCel DxH
Sysmex Develops Reagent for Testing Hepatic Fibrosis

6. RECENT INDUSTRY ACTIVITY

Beckman Coulter Receives FDA Clearance for AQUIOS CL Flow Cytometer
Bio-Rad Laboratories Extends Agreement with Beckman Coulter
Sysmex to Expand US Reagent Factory
Sysmex to Establish New R&D Lab
Siemens Healthcare Joins CANCER-ID Consortium
Sysmex Expands Reagent Factory in Germany
EMD Millipore Collaborates with Sysmex
eBioscience Inks Distribution Agreement with Binding Site Group
The Carlyle Group Acquires Johnson & Johnson’s Ortho-Clinical Diagnostics Business
Beckman Coulter Bags FDA Clearance for Power Express Sample Processing System
Beckman Coulter Signs New Installation Agreement with PCL Alverno
Beckman Coulter Teams Up with hc1. com
Sysmex Launches i-Square Instrument Factory
Sysmex Renames Partec as Sysmex Partec
Beckman Coulter Life Sciences to Acquire Xitogen Technologies
Sysmex Establishes Sysmex Australia
Beckman Coulter Life Sciences Receives FDA Approval for Navios
Thorlabs Snaps Up CompuCyte
Beckman Coulter Inks New Tri Source Agreement with Premier
Beckman Coulter Receives FDA Clearance for its Access AccuTnI+3 Troponin I Assay
Sysmex Inks Collaboration Agreement with National Cancer Center
Sysmex Acquires Partec
Beckman Coulter Life Sciences Acquires ReaMetrix India’s Flow Cytometry Business
Sysmex Takes Over Dong Kang Medipia

7. FOCUS ON SELECT GLOBAL PLAYERS

Abbott Laboratories (US)
BD Biosciences (US)
Beckman Coulter, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
CellaVision AB (Sweden)
Dako Denmark A/S (Denmark)
eBioscience, Inc. (US)
EMD Millipore (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Grifols, S. A (Spain)
Horiba Ltd. (Japan)
Mindray Medical International Limited (China)
Ortho-Clinical Diagnostics, Inc. (US)
QIAGEN N. V. (The Netherlands)
Siemens Healthcare (Germany)
Sysmex Corporation (Japan)
Thermo Fisher Scientific, Inc. (US)

8. GLOBAL MARKET PERSPECTIVE

Table 7. World Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 8. World Historic Review for Cell Surface Markers Identification Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 9. World 14-Year Perspective for Cell Surface Markers Identification Equipment by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

Table 10. World Recent Past, Current and Future Analysis for Flow Cytometers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 11. World Historic Review for Flow Cytometers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 12. World 14-Year Perspective for Flow Cytometers by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

Table 13. World Recent Past, Current and Future Analysis for Others by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 14. World Historic Review for Others by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 15. World 14-Year Perspective for Others by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

Table 16. World Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Application - Research and Diagnosis Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 17. World Historic Review for Cell Surface Markers Identification Equipment by Application - Research and Diagnosis Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 18. World 14-Year Perspective for Cell Surface Markers Identification Equipment by Application - Percentage Breakdown of Revenues for Research and Diagnosis Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Outlook
Largest Market for Cell Surface Markers Identification Equipment
Increased Focus on Cancer Care to Benefit Market
Cancer Statistics

Table 19. New Cancer Cases in the US by Gender and Affected Site: 2014

Table 20. Cancer Related Deaths in the US by Gender and Body Site: 2014

Recovery in Lab Investments to Support Growth
Product Innovations Focus on High Volume Applications
Competitive Scenario
BD Biosciences & Beckman Coulter Dominate Flow Cytometers Market

Table 21. Leading Players in the US Flow Cytometry Market (2014): Percentage Breakdown of Value Sales for Becton Dickinson and Company (BD)/BD Biosciences, Danaher/ Beckman Coulter and Others (includes corresponding Graph/Chart)

Product Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 22. US Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 23. US Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 24. US 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
High Focus on Improving Healthcare Augurs Well for Market Growth
B. Market Analytics

Table 25. Canadian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 26. Canadian Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 27. Canadian 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Outlook
Product Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 28. Japanese Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 29. Japanese Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 30. Japanese 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Outlook
European Debt Crisis Weakens Market Momentum in 2012 & 2013
B. Market Analytics

Table 31. Europe Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 32. Europe Historic Review for Cell Surface Markers Identification Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 33. Europe 14-Year Perspective for Cell Surface Markers Identification Equipment by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

Table 34. Europe Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 35. Europe Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 36. Europe 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

4A. FRANCE

A. Market Analysis
Outlook
B. Market Analytics

Table 37. French Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 38. French Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Outlook
Strategic Corporate Developments
Siemens Healthcare – A Major German Player
B. Market Analytics

Table 39. German Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 40. German Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Outlook
B. Market Analytics

Table 41. Italian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 42. Italian Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Outlook
Product Launches
B. Market Analytics

Table 43. UK Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 44. UK Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4E. SPAIN

A. Market Analysis
Outlook
Grifols, S. A – A Major Spanish Player
B. Market Analytics

Table 45. Spanish Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 46. Spanish Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4F. RUSSIA

A. Market Analysis
Outlook
B. Market Analytics

Table 47. Russian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 48. Russian Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Outlook
Product Launches
Select Key Players
B. Market Analytics

Table 49. Rest of Europe Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 50. Rest of Europe Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Outlook
Asia-Pacific: The Fastest Growing Regional Market
B. Market Analytics

Table 51. Asia-Pacific Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 52. Asia-Pacific Historic Review for Cell Surface Markers Identification Equipment by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 53. Asia-Pacific 14-Year Perspective for Cell Surface Markers Identification Equipment by Geographic Region - Percentage Breakdown of Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

Table 54. Asia-Pacific Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 55. Asia-Pacific Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 56. Asia-Pacific 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

5A. CHINA

A. Market Analysis
Outlook
Domestic Companies Compete with MNCs
Corporate Development
Mindray Medical International Limited – A Major Chinese Player
B. Market Analytics

Table 57. Chinese Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 58. Chinese Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5B. INDIA

A. Market Analysis
Outlook
Indian Flow Cytometry Market: An Overview

Table 59. Flow Cytometry Market in India (2014): Percentage Breakdown of Sales by End-Use Industry - Life Sciences, Clinical Research and Pharmaceutical (includes corresponding Graph/Chart)

Table 60. Indian Market for Flow Cytometers Reagents (2014): Percentage Share Breakdown of Value Sales by Application (includes corresponding Graph/Chart)

Automated Hematology Analyzers Gaining Traction
Corporate Development
B. Market Analytics

Table 61. Indian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 62. Indian Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5C. REST OF ASIA-PACIFIC

A. Market Analysis
Outlook
Strategic Corporate Developments
B. Market Analytics

Table 63. Rest of Asia-Pacific Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 64. Rest of Asia-Pacific Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. LATIN AMERICA

A. Market Analysis
Outlook
B. Market Analytics

Table 65. Latin America Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 66. Latin America Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 67. Latin America 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
Outlook
B. Market Analytics

Table 68. Rest of World Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 69. Rest of World Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 70. Rest of World 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 79 (including Divisions/Subsidiaries - 105)
The United States (47)
Canada (1)
Japan (8)
Europe (30)
  France (4)
  Germany (8)
  The United Kingdom (5)
  Italy (1)
  Spain (2)
  Rest of Europe (10)
Asia-Pacific (Excluding Japan) (18)
Latin America (1)